Tag: Medtronic

February 26, 2024

Last week, Medtronic said it would shut down its ventilator product lines and reorganize the remaining patient monitoring and respiratory interventions businesses into a new unit, called Acute Care and Monitoring. The decision reverses a planned spin-off of the businesses […]

January 31, 2024

The medical device industry is set up for an eventful year after weathering numerous challenges for the past four years due to the COVID-19 pandemic and other macroeconomic factors. Last year, device companies found some stability as those pressures eased, […]

November 10, 2023

Acutus developed mapping technology to try to reduce the rate of atrial fibrillation recurrence after patients undergo ablation. The company pitched its non-contact approach to mapping as a better fit for atrial fibrillation and other complex or unstable arrhythmias, but […]

September 1, 2023

Beta Bionics raised a $57 million series C financing round early last year. That financing, which was co-led by a syndicate of venture capital funds with an assist from strategic partner Novo Nordisk, equipped the company to develop iLet, file […]

May 2, 2023

In the multibillion-dollar market for diabetes technology, Medtronic’s U.S. diabetes sales have declined in the last four years as the company grappled with regulators and competitors rolled out new devices. With two strokes of a pen in late April, the […]

April 14, 2023

Medtronic bought Epix for a catheter-based, temperature-controlled cardiac ablation system designed to treat patients with irregular heartbeats including atrial fibrillation. Two years after making the deal, Medtronic received U.S. Food and Drug Administration approval for the device. To acquire DiamondTemp, […]

February 8, 2022

If 2021 set the stage for the next few years’ worth of developments in surgical robotics, then it stands to reason 2022 will pay off on some of those actions. One of those actions is the continued development of new […]

January 18, 2022

In 2017, Medtronic was significantly impacted by multiple natural disasters all in the same fiscal quarter, but managed to weather those disasters by bending, not breaking. While we have not seen any reports yet of any medical device manufacturers being […]

February 11, 2020

PALM BEACH, Florida, Feb. 11, 2020 /PRNewswire/ — There is no doubt that the global medical device market has been showing outstanding growth for the last few years and that it will continue to do so in the near future… […]

April 8, 2019

Targeted drug delivery and conventional medical management have shown to have a reduction in healthcare use and costs for cancer patients in comparison to conventional medical management alone, according to a new study from Medtronic. The study found that there […]

March 4, 2019

Medtronic (NYSE:MDT) has registered for a new undisclosed debt offering based in the European Union, according to recently posted SEC filings. The company will look to offer a slew of new general unsecured senior notes in the funding round, according […]

February 21, 2019

Medtronic (NYSE:MDT) said this week that it plans to close its Portsmouth, N.H.-based transformative solutions facility within the year, according to a Portsmouth Herald report. The Fridley, Minn.-based company recently informed employees at the facilities that it planned to eliminate […]

February 19, 2019

Medtronic (NYSE:MDT) said today that it won breakthrough status from the FDA for its investigational personalized closed-loop insulin pump system. The company touted its technology as enabling automated insulin delivery in a real-time, adaptable and personalized fashion. Medtronic’s November acquisition […]

January 3, 2019

Several medical device companies took hits yesterday after analysts on Wall Street downgraded their stocks, on a day when the major market indices each closed up a hair, and even medtech firms that enjoyed upgrades came under pressure. Globus Medical […]

September 21, 2018

Medtronic (NYSE:MDT) is all-in on the surgical robotics game now that’s inked a deal to buy Mazor Robotics (NSDQ:MZOR) for more than $1.6 billion in cash. The world’s largest medical device maker has held a position in Mazor, which makes […]

September 10, 2018

Medtronic (NYSE:MDT) said today that it’s launching a study in the U.S. and Japan to evaluate dual antiplatelet therapy in high bleeding risk patients implanted with the Resolute Onyx drug-eluting stent during percutaneous coronary intervention. The company’s Onyx One Clear […]

August 10, 2018

Medtronic (NYSE:MDT) said yesterday it launched a pilot study of its investigational Extravascular Implantable cardioverter defibrillator system, with the first patient implant already performed at New Zealand’s Christchurch Hospital. The Fridley, Minn.-based company’s EV ICD system uses leads placed outside […]

April 10, 2018

Medtronic (NYSE:MDT) said today that it won CE Mark approval in the European Union for its Visualase brain surgery device. Fridley, Minn.-based Medtronic said the MRI-guided Visualase system uses a small-diameter probe to deliver laser energy to ablate soft tissue […]

September 18, 2017

Medtronic (NYSE:MDT) said today it won FDA approval for its Intellis implantable spinal cord stimulation system and launched it in the US. The Fridley, Minn.-based company touted the newly revised system as the world’s smallest, and said that the new […]

September 15, 2017

Mazor Robotics (NSDQ:MZOR) said today that closed the third, $40 million tranche of a deal with Medtronic (NYSE:MDT), which is due to take on exclusive global distribution rights for the Mazor X robot-assisted surgery device. It’s the third investment in […]